TyraTech (AIM: TYR) – well placed to launch a ‘bug attack’
We follow up on our AimZine article published last month, with more positive news from TyraTech.
Today this life sciences company, focusing on nature-derived insect and parasite control products, has announced that its Vamousse head lice products are to be listed by AmerisourceBergen, the second biggest distributor of pharmaceutical products in the USA. This agreement follows the recently announced listings for Vamousse obtained with McKesson and Cardinal Health, the number one and number three distributors of pharmaceutical products in the USA respectively. These three distributors had an estimated combined sales of more than $350b in 2014, hence these listings represent an important milestone for Tyratech. They provide the essential first step in accessing the approximate 20,000…